CIMG Inc. Liquidation Value

CIMG Drug Stores

Cash & Equivalents

$17,025
As of 2026-03-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $17,025
Total Obligations: -$12.10M
$-12.08M
Per share: $-0.13
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $17,025
AR: $1.39M
Total Obligations: -$12.10M
$-10.70M
Per share: $-0.12
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $17,025
AR: $1.39M
Inventory: N/A
Total Obligations: -$12.10M
$-10.70M
Per share: $-0.12
Period: 2026-03-31
incomplete 2 components missing — treated as $0 in formula. Why?
  • Inventory: not reported in this period (annual-only)
  • Long-Term Debt: not reported in this period (annual-only)

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-12.08M$-0.13
Liquid Liquidation Value$-10.70M$-0.12
Operating Liquidation Value$-10.70M$-0.12

Key Components (as of 2026-03-31)

Data as of 2026-03-31 from 10-Q filed 2026-05-11. View on SEC EDGAR →

Cash & Equivalents$17,025
Accounts Receivable$1.39M
InventoryN/A
Current Liabilities$12.09M
Long-term Debt (?)N/A
Op. Lease Liability (?)$0
Finance Lease (?)N/A
Shares Outstanding90.0M

Explore all 127 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$17,025$1.39MN/A$1.77M$12.09MN/A$0N/A
2025-12-31$45,356$1.39M$157$1.79M$10.90MN/A$0N/A

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-05-11 View
2025-12-31 10-Q/A 2026-03-19 View
2025-12-31 10-Q 2026-03-05 View
2025-09-30 10-K 2026-02-13 View
2025-06-30 10-Q/A 2025-11-07 View
2025-06-30 10-Q 2025-11-03 View
2025-03-31 10-Q/A 2025-11-18 View
2025-03-31 10-Q 2025-09-24 View

AI Insights

AI Insight·Generated 2026-05-12

CIMG Inc. (ticker: CIMG) presents a deeply negative liquidation posture as of March 31, 2026. The company's own MFFAIS-computed cash liquidation value stands at approximately negative $10.9 million, with liquid and operating liquidation values at approximately negative $9.5 million. These figures reflect the structural asymmetry under the liquidation lens: haircut assets against face-value liabilities. The filing body provides several materially relevant disclosures that sharpen this assessment.

Cash is effectively exhausted: the filing discloses a cash balance of $17,025 at March 31, 2026, down from approximately $50,000 at December 31, 2025. Under the liquidation lens, cash recovers at 100%, contributing negligible asset value. Taxes payable increased from $1.31 million (September 30, 2025) to $2.43 million (March 31, 2026), driven almost entirely by accrued sales taxes — a face-value liability under liquidation. Related-party payables total $1.97 million as of March 31, 2026, unsecured and non-interest bearing per the filing, but they remain face-value obligations in a wind-down. A provision for directors' litigation of $222,062 was recognized as an adjusting subsequent event (default judgment in the Ex-Directors lawsuit). Professional service fees payable to Sunflower Tech Limited for a Bitcoin-related financial advisory engagement total $2.09 million at March 31, 2026, reduced from $3.66 million at September 30, 2025 — a contractual accrued liability sitting at face value in liquidation.

The accumulated deficit reached approximately $122.1 million as of March 31, 2026, up from approximately $106.7 million at December 31, 2025, implying a net loss of approximately $15.4 million in Q2 alone. For the six months ended March 31, 2026, net loss totaled $34.9 million, of which $31.6 million is attributable to fair value variation in digital assets (Bitcoin). The filing discusses Bitcoin holdings and associated fair value variation extensively in MD&A and segment reporting, identifying it as the dominant driver of net loss — but no separate XBRL balance-sheet tag for digital assets appears in TAG_CONTEXT. This is a material omission: the filing references a $55 million Bitcoin-related private placement transaction and significant Bitcoin-related operating cash outflows ($10.1 million cash used in operations for H1 FY2026, primarily attributed to digital asset purchases), yet the digital asset balance sheet line is not separately XBRL-tagged.

Revenue of $19.0 million for the six months ended March 31, 2026 carries a gross margin of 0.53%, meaning the operating business generates virtually no contribution to the liability stack. Operating expenses of $3.4 million for the period, combined with the gross margin of $101,069, produces a loss from operations of $3.3 million before the digital asset fair value charge. PP&E net is de minimis ($1,150 in China as of March 31, 2026). The company has no separately disclosed long-term debt other than the convertible notes issued in February 2026 (initial tranche $1.6 million, 7% interest, maturity August 2027); these are not yet converted and represent face-value claims in liquidation. Subsequent to the period, a further $3.4 million equity facility with High West Partners LLC was approved, with shares issuable at discounts as deep as 15% to VWAP.

Nasdaq delisted the company effective March 6, 2026; the stock now trades OTC. Internal controls are disclosed as not effective. Management's going concern assessment is unalleviated. Recovery to equity in a liquidation scenario is negative and materially so.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...